Abiant is using advanced imaging technology to
accelerate the development of new therapeutics and
the diagnosis of disease. A primary focus is on the
central nervous system, with additional applications in
oncology and inflammation.
Using proprietary data collection, processing, and
analysis methods, we conduct imaging studies to
provide critical, reliable information regarding
compound action. This information can help
pharmaceutical developers to make earlier drug
development decisions, reducing time, cost, and risk.
The same core technology is being applied to achieve
the early, accurate differential diagnosis of diseases
such as Alzheimer's.
With a team approach, we are combining scientific and
operational excellence in order to meet our customers'
needs and to advance the treatment of disease.
accelerate the development of new therapeutics and
the diagnosis of disease. A primary focus is on the
central nervous system, with additional applications in
oncology and inflammation.
Using proprietary data collection, processing, and
analysis methods, we conduct imaging studies to
provide critical, reliable information regarding
compound action. This information can help
pharmaceutical developers to make earlier drug
development decisions, reducing time, cost, and risk.
The same core technology is being applied to achieve
the early, accurate differential diagnosis of diseases
such as Alzheimer's.
With a team approach, we are combining scientific and
operational excellence in order to meet our customers'
needs and to advance the treatment of disease.
| Copyright 2006-2009 Abiant, Inc. |
About Us
 | |  | |  | |  |
Advanced BioImaging to Accelerate New Therapeutics
| Accelerating diagnosis and treatment |
| Understanding disease and compound action |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |